Key result
The American Heart Association's Advanced Cardiac Life Support 2000 guidelines incorporate new medications, including amiodarone and vasopressin, for the treatment of cardiac arrest.
Answers are grounded in this paper and cite their sources.
The ACLS 2000 guidelines introduced significant pharmacotherapeutic changes for cardiac resuscitation, notably the addition of amiodarone and vasopressin.
The treatment of sudden cardiac death is a challenging area of pharmacotherapy. Despite decades of medication use, outcomes from the treatment of cardiac arrest remain poor. Recent advances in the treatment of cardiac arrest have been incorporated into the American Heart Association’s Advanced Cardiac Life Support 2000 guidelines. A summary and review of these guidelines are presented. Included in the changes to the cardiac arrest treatment guidelines are new medications (amiodarone and vasopressin), new approaches to using medications and the evidence to support these changes. The implications of instituting these new guidelines and strategies for the implementation of the new paradigm are discussed.
No takes yet. Share an insight, caveat, or question.
Robert DiGregorio (2001) conducted a review in Sudden cardiac death / cardiac arrest. Advanced Cardiac Life Support (ACLS) 2000 guidelines was evaluated. The American Heart Association's Advanced Cardiac Life Support 2000 guidelines incorporate new medications, including amiodarone and vasopressin, for the treatment of cardiac arrest.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: